How bacterial pathogens eat host lipids: Implications for the development of fatty acid synthesis therapeutics

Journal of Biological Chemistry

Volumn 290, Issue 10, 2015, Pages 5940-5946

  Yao, Jiangwei ^a   Rock, Charles O ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA; LIPIDS; PATHOGENS;

BACTERIAL PATHOGENS; BROAD SPECTRUM; ESSENTIAL FATTY ACIDS; EXTRACELLULAR; FATTY ACID SYNTHESIS; MEMBRANE LIPIDS; TYPE II FATTY ACID SYNTHESIS;

FATTY ACIDS;

FATTY ACID; LIPID; LONG CHAIN FATTY ACID COENZYME A LIGASE; PHOSPHOLIPID; THIOCTIC ACID; ANTIINFECTIVE AGENT; FATTY ACID SYNTHASE; MEMBRANE LIPID;

BACTERIAL CELL; BACTERIAL INFECTION; BACTERIAL METABOLISM; BACTERIAL VIRULENCE; BINDING AFFINITY; DRUG TARGETING; ESCHERICHIA COLI; FATTY ACID METABOLISM; FATTY ACID SYNTHESIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOST; LIPID ANALYSIS; LIPOGENESIS; MICROBIAL ACTIVITY; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; TYPE II SECRETION SYSTEM; ANTAGONISTS AND INHIBITORS; BACTERIUM; BIOSYNTHESIS; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; PATHOGENICITY;

BACTERIA (MICROORGANISMS); NEGIBACTERIA;

ANTI-BACTERIAL AGENTS; BACTERIA; FATTY ACID SYNTHASE, TYPE II; FATTY ACIDS; HOST-PATHOGEN INTERACTIONS; HUMANS; LIPOGENESIS; MEMBRANE LIPIDS;

EID: 84924939876     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.R114.636241     Document Type: Short Survey

References (77)

1. Piddock, L. J. (2012) The crisis of no new antibiotics: what is the way forward? Lancet Infect. Dis. 12, 249-253
2. Levy, S. B., and Marshall, B. (2004) Antibacterial resistance worldwide: causes, challenges and responses. Nat. Med. 10, S122-S129
3. Davies, J., and Davies, D. (2010) Origins and evolution of antibiotic resistance. Microbiol. Mol. Biol. Rev. 74, 417-433
4. Lewis, K. (2013) Platforms for antibiotic discovery. Nat. Rev. Drug Discov. 12, 371-387
5. Wang, Y., and Ma, S. (2013) Recent advances in inhibitors of bacterial fatty acid synthesis type II (FASII) system enzymes as potential antibacterial agents. Chem. Med. Chem. 10.1002/cmdc.201300209
6. Parsons, J. B., and Rock, C. O. (2011) Is bacterial fatty acid synthesis a valid target for antibacterial drug discovery? Curr. Opin. Microbiol. 14, 544-549
7. Wright, H. T., and Reynolds, K. A. (2007) Antibacterial targets in fatty acid biosynthesis. Curr. Opin. Microbiol. 10, 447-453
8. Smith, S., Witkowski, A., and Joshi, A. K. (2003) Structural and functional organization of the animal fatty acid synthase. Prog. Lipid Res. 42, 289-317
9. Parsons, J. B., and Rock, C. O. (2013) Bacterial lipids: metabolism and membrane homeostasis. Prog. Lipid Res. 52, 249-276
10. Freiberg, C., Pohlmann, J., Nell, P. G., Endermann, R., Schuhmacher, J., Newton, B., Otteneder, M., Lampe, T., Häbich, D., and Ziegelbauer, K. (2006) Novel bacterial acetyl-coenzyme A carboxylase inhibitors with antibiotic efficacy in vivo. Antimicrob. Agents Chemother 50, 2707-2712
11. Banevicius, M. A., Kaplan, N., Hafkin, B., and Nicolau, D. P. (2013) Pharmacokinetics, pharmacodynamics and efficacy of novel FabI inhibitor AFN-1252 against MSSA and MRSA in the murine thigh infection model. J. Chemother 25, 26-31
12. Escaich, S., Prouvensier, L., Saccomani, M., Durant, L., Oxoby, M., Gerusz, V., Moreau, F., Vongsouthi, V., Maher, K., Morrissey, I., and Soulama-Mouze, C. (2011) The MUT056399 inhibitor of FabI is a new antistaphylococcal compound. Antimicrob. Agents Chemother 55, 4692-4697
13. Schiebel, J., Chang, A., Shah, S., Lu, Y., Liu, L., Pan, P., Hirschbeck, M. W., Tareilus, M., Eltschkner, S., Yu, W., Cummings, J. E., Knudson, S. E., Bommineni, G. R., Walker, S. G., Slayden, R. A., Sotriffer, C. A., Tonge, P. J., and Kisker, C. (2014) Rational design of broad spectrum antibacterial activity based on a clinically relevant enoyl-acyl carrier protein (ACP) reductase inhibitor. J. Biol. Chem. 289, 15987-16005
14. Kaplan, N., Garner, C., and Hafkin, B. (2013) AFN-1252 in vitro absorption studies and pharmacokinetics following microdosing in healthy subjects. Eur. J. Pharm. Sci. 50, 440-446
15. Gerusz, V., Denis, A., Faivre, F., Bonvin, Y., Oxoby, M., Briet, S., LeFralliec, G., Oliveira, C., Desroy, N., Raymond, C., Peltier, L., Moreau, F., Escaich, S., Vongsouthi, V., Floquet, S., Drocourt, E., Walton, A., Prouvensier, L., Saccomani, M., Durant, L., Genevard, J. M., Sam-Sambo, V., and Soulama-Mouze, C. (2012) From triclosan toward the clinic: discovery of nonbiocidal, potent FabI inhibitors for the treatment of resistant bacteria. J. Med. Chem. 55, 9914-9928
16. Brinster, S., Lamberet, G., Staels, B., Trieu-Cuot, P., Gruss, A., and Poyart, C. (2009) Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens. Nature 458, 83-86
17. Parsons, J. B., Frank, M. W., Subramanian, C., Saenkham, P., and Rock, C. O. (2011) Metabolic basis for the differential susceptibility of Gram-positive pathogens to fatty acid synthesis inhibitors. Proc. Natl. Acad. Sci. U.S.A. 108, 15378-15383
18. Parsons, J. B., Frank, M. W., Jackson, P., Subramanian, C., and Rock, C. O. (2014) Incorporation of extracellular fatty acids by a fatty acid kinase-dependent pathway in Staphylococcus aureus. Mol. Microbiol. 92, 234-245
19. Parsons, J. B., Broussard, T. C., Bose, J. L., Rosch, J. W., Jackson, P., Subramanian, C., and Rock, C. O. (2014) Identification of a two-component fatty acid kinase responsible for host fatty acid incorporation by Staphylococcus aureus. Proc. Natl. Acad. Sci. U.S.A. 111, 10532-10537
20. Heath, R. J., White, S. W., and Rock, C. O. (2001) Lipid biosynthesis as a target for antibacterial agents. Prog. Lipid Res. 40, 467-497
21. Cronan, J. E., Jr., and Rock, C. O. (2008) Chapter 3.6.4. Biosynthesis of membrane lipids. In Eco-Sal-Escherichia coli and Salmonella typhimurium: cellular and molecular biology (Böck, I., Curtis III, R., Kaper, J. B., Karp, P. D., Neidhardt, F. C., Nyström, T., Slauch, J. M., Squires, C. L., and Ussery, D., eds), ASM Press, Washington, DC, 10.1128/ecosalplus.3.6.4
22. Rock, C. O., and Jackowski, S. (2002) Forty years of fatty acid biosynthesis. Biochem. Biophys. Res. Commun. 292, 1155-1166
23. Green, P. R., Merrill, A. H., Jr., and Bell, R. M. (1981) Membrane phospholipid synthesis in Escherichia coli: purification, reconstitution, and characterization of sn-glycerol-3-phosphate acyltransferase. J. Biol. Chem. 256, 11151-11159
24. Coleman, J. (1992) Characterization of the Escherichia coli gene for 1-acyl-sn-glycerol-3-phosphate acyltransferase (plsC). Mol. Gen. Genet. 232, 295-303
25. Yao, J., and Rock, C. O. (2013) Phosphatidic acid synthesis in bacteria. Biochim. Biophys. Acta 1831, 495-502
26. Nikaido, H. (1968) Biosynthesis of cell wall lipopolysaccharide in gram-negative enteric bacteria. Adv. Enzymol. Relat. Areas Mol. Biol. 31, 77-124
27. Raetz, C. R. H. (1978) Enzymology, genetics, and regulation of membrane phospholipid synthesis in Escherichia coli. Microbiol. Rev. 42, 614-659
28. Raetz, C. R. H. (1987) Structure and biosyntheis of lipid A in Escherichia coli. In Escherichia coli and Salmonella typhimurium: Cellular and Molecular Biology (Neidhardt, F. C., Ingraham, J. L., Low, K. B., Magasanik, B., Schaechter, M., and Umbarger, H., eds), pp. 498-503, American Society for Microbiology, Washington, D.C.
29. Heath, R. J., Rubin, J. R., Holland, D. R., Zhang, E., Snow, M. E., and Rock, C. O. (1999) Mechanism of triclosan inhibition of bacterial fatty acid synthesis. J. Biol. Chem. 274, 11110-11114
30. Li, X., Uchiyama, T., Raetz, C. R., and Hindsgaul, O. (2003) Synthesis of a carbohydrate-derived hydroxamic acid inhibitor of the bacterial enzyme (LpxC) involved in lipid A biosynthesis. Org. Lett. 5, 539-541
31. Black, P. N., DiRusso, C. C., Metzger, A. K., and Heimert, T. L. (1992) Cloning, sequencing, and expression of the fadD gene of Escherichia coli encoding acyl coenzyme A synthetase. J. Biol. Chem. 267, 25513-25520
32. Weeks, G., Shapiro, M., Burns, R. O., and Wakil, S. J. (1969) Control of fatty acid metabolism. I. Induction of the enzymes of fatty acid oxidation in Escherichia coli. J. Bacteriol. 97, 827-836
33. Overath, P., and Raufuss, E. M. (1967) The induction of the enzymes of fatty acid degradation in Escherichia coli. Biochem. Biophys. Res. Commun. 29, 28-33
34. Cronan, J. E., Jr., and Subrahmanyam, S. (1998) FadR, transcriptional coordination of metabolic expediency. Mol. Microbiol. 29, 937-943
35. Ray, T. K., and Cronan, J. E., Jr. (1976) Activation of long chain fatty acids with acyl carrier protein: demonstration of a new enzyme, acyl-acyl carrier protein synthetase, in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 73, 4374-4378
36. Jackowski, S., Jackson, P. D., and Rock, C. O. (1994) Sequence and function of the aas gene in Escherichia coli. J. Biol. Chem. 269, 2921-2928
37. Cooper, C. L., Hsu, L., Jackowski, S., and Rock, C. O. (1989) 2-Acylglycerolphosphoethanolamine acyltransferase/acyl-acyl carrier protein synthetase is a membrane-associated acyl carrier protein binding protein. J. Biol. Chem. 264, 7384-7389
38. Hsu, L., Jackowski, S., and Rock, C. O. (1991) Isolation and characterization of Escherichia coli K-12 mutants lacking both 2-acyl-glycerophosphoethanolamine acyltransferase and acyl-acyl carrier protein synthetase activity. J. Biol. Chem. 266, 13783-13788
39. Rock, C. O., and Garwin, J. L. (1979) Preparative enzymatic synthesis and hydrophobic chromatography of acyl-acyl carrier protein. J. Biol. Chem. 254, 7123-7128
40. Byers, D. M. (1989) Elongation of exogenous fatty acids by the bioluminescent bacterium Vibrio harveyi. J. Bacteriol. 171, 59-64
41. Fice, D., Shen, Z., and Byers, D. M. (1993) Purification and characterization of fatty acyl-acyl carrier protein synthetase from Vibrio harveyi. J. Bacteriol. 175, 1865-1870
42. Jiang, Y., Chan, C. H., and Cronan, J. E. (2006) The soluble acyl-acyl carrier protein synthetase of Vibrio harveyi B392 is a member of the medium chain acyl-CoA synthetase family. Biochemistry 45, 10008-10019
43. Lu, Y.-J., Zhang, Y.-M., Grimes, K. D., Qi, J., Lee, R. E., and Rock, C. O. (2006) Acyl-phosphates initiate membrane phospholipid synthesis in gram-positive pathogens. Molec. Cell 23, 765-772
44. Lu, Y.-J., and Rock, C. O. (2006) Transcriptional regulation of fatty acid biosynthesis in Streptococcus pneumoniae. Mol. Microbiol. 59, 551-566
45. Jerga, A., and Rock, C. O. (2009) Acyl-acyl carrier protein regulates transcription of fatty acid biosynthetic genes via the FabT repressor in Streptococcus pneumoniae. J. Biol. Chem. 284, 15364-15368
46. Davis, M. S., and Cronan, J. E., Jr. (2001) Inhibition of Escherichia coli acetyl coenzyme A carboxylase by acyl-acyl carrier protein. J. Bacteriol. 183, 1499-1503
47. Denou, E., Pridmore, R. D., Berger, B., Panoff, J. M., Arigoni, F., and Brüssow, H. (2008) Identification of genes associated with the long-gut-persistence phenotype of the probiotic Lactobacillus johnsonii strain NCC533 using a combination of genomics and transcriptome analysis. J. Bacteriol. 190, 3161-3168
48. Muller, J. A., Ross, R. P., Sybesma, W. F. H., Fitzgerald, G. F., and Stanton, C. (2011) Modification of the technical properties of Lactobacillus johnsonii NCC 533 by supplementing the growth medium with unsaturated fatty acids. Appl. Environ. Microbiol. 77, 6889-6898
49. Williams, W. L., Broquist, H. P., and Snell, E. E. (1947) Oleic acid and related compounds as growth factors for lactic acid bacteria. J. Biol. Chem. 170, 619-630
50. Collado, M. C., Meriluoto, J., and Salminen, S. (2007) Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus. Lett. Appl. Microbiol. 45, 454-460
51. Sherman, P. M., Johnson-Henry, K. C., Yeung, H. P., Ngo, P. S. C., Goulet, J., and Tompkins, T. A. (2005) Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements. Infect. Immun. 73, 5183-5188
52. Schujman, G. E., Paoletti, L., Grossman, A. D., and de Mendoza, D. (2003) FapR, a bacterial transcription factor involved in global regulation of membrane lipid biosynthesis. Dev. Cell 4, 663-672
53. Albanesi, D., Reh, G., Guerin, M. E., Schaeffer, F., Debarbouille, M., Buschiazzo, A., Schujman, G. E., de Mendoza, D., and Alzari, P. M. (2013) Structural basis for feed-forward transcriptional regulation of membrane lipid homeostasis in Staphylococcus aureus. PLoS Pathog. 9, e1003108
54. Kaplan, N., Awrey, D., Bardouniotis, E., Berman, J., Yethon, J., Pauls, H. W., and Hafkin, B. (2013) In vitro activity (MICs and rate of kill) of AFN-1252, a novel FabI inhibitor, in the presence of serum and in combination with other antibiotics. J. Chemother. 25, 18-25
55. Kaplan, N., Albert, M., Awrey, D., Bardouniotis, E., Berman, J., Clarke, T., Dorsey, M., Hafkin, B., Ramnauth, J., Romanov, V., Schmid, M. B., Thalakada, R., Yethon, J., and Pauls, H. W. (2012) Mode of action, in vitro activity, and in vivo efficacy of AFN-1252, a selective antistaphylococcal FabI inhibitor. Antimicrob. Agents Chemother. 56, 5865-5874
56. Yao, J., Maxwell, J. B., and Rock, C. O. (2013) Resistance to AFN-1252 arises from missense mutations in Staphylococcus aureus enoyl-acyl carrier protein reductase (FabI). J. Biol. Chem. 288, 36261-36271
57. Parsons, J. B., Kukula, M., Jackson, P., Pulse, M., Simecka, J. W., Valtierra, D., Weiss, W. J., Kaplan, N., and Rock, C. O. (2013) Perturbation of Staphylococcus aureus gene expression by the enoyl-acyl carrier protein reductase inhibitor AFN-1252. Antimicrob. Agents Chemother. 57, 2182-2190
58. Becker, Y. (1978) The Chlamydia: molecular biology of procaryotic obligate parasites of eucaryocytes. Microbiol. Rev. 42, 274-306
59. Yao, J., Abdelrahman, Y. M., Robertson, R. M., Cox, J. V., Belland, R. J., White, S. W., and Rock, C. O. (2014) Type II fatty acid synthesis is essential for the replication of Chlamydia trachomatis. J. Biol. Chem. 289, 22365-22376
60. Stephens, R. S., Kalman, S., Lammel, C., Fan, J., Marathe, R., Aravind, L., Mitchell, W., Olinger, L., Tatusov, R. L., Zhao, Q., Koonin, E. V., and Davis, R. W. (1998) Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 282, 754-759
61. Wylie, J. L., Hatch, G. M., and McClarty, G. (1997) Host cell phospholipids are trafficked to and then modified by Chlamydia trachomatis. J. Bacteriol. 179, 7233-7242
62. Nguyen, B. D., Cunningham, D., Liang, X., Chen, X., Toone, E. J., Raetz, C. R., Zhou, P., and Valdivia, R. H. (2011) Lipooligosaccharide is required for the generation of infectious elementary bodies in Chlamydia trachomatis. Proc. Natl. Acad. Sci. U.S.A. 108, 10284-10289
63. Zhang, Y.-M., and Rock, C. O. (2008) Membrane lipid homeostasis in bacteria. Nat. Rev. Microbiol. 6, 222-233
64. Singh, V. K., Hattangady, D. S., Giotis, E. S., Singh, A. K., Chamberlain, N. R., Stuart, M. K., and Wilkinson, B. J. (2008) Insertional inactivation of branched-chain α-keto acid dehydrogenase in Staphylococcus aureus leads to decreased branched-chain membrane fatty acid content and increased susceptibility to certain stresses. Appl. Environ. Microbiol. 74, 5882-5890
65. Parsons, J. B., Frank, M. W., Rosch, J. W., and Rock, C. O. (2013) Staphylococcus aureus fatty acid auxotrophs do not proliferate in mice. Antimicrob. Agents Chemother. 57, 5729-5732
66. Kaneda, T. (1991) Iso- and anteiso-fatty acids in bacteria: biosynthesis, function, and taxonomic significance. Microbiol. Rev. 55, 288-302
67. Vanden Boom, T. J., Reed, K. E., and Cronan, J. E., Jr. (1991) Lipoic acid metabolism in Escherichia coli: isolation of null mutants defective in lipoic acid biosynthesis, molecular cloning and characterization of the E. coli lip locus, and identification of the lipoylated protein of the glycine cleavage system. J. Bacteriol. 173, 6411-6420
68. Cronan, J. E., Jr. (1988) Expression of the biotin biosynthetic operon of Escherichia coli is regulated by the rate of protein biotination. J. Biol. Chem. 263, 10332-10336
69. Vinale, F., Girona, I. A., Nigro, M., Mazzei, P., Piccolo, A., Ruocco, M., Woo, S., Rosa, D. R., Herrera, C. L., and Lorito, M. (2012) Cerinolactone, a hydroxy-lactone derivative from Trichoderma cerinum. J. Nat. Prod. 75, 103-106
70. Moré, M. I., Finger, L. D., Stryker, J. L., Fuqua, C., Eberhard, A., and Winans, S. C. (1996) Enzymatic synthesis of a quorum-sensing autoinducer through use of defined substrates. Science 272, 1655-1658
71. Pelz, A., Wieland, K. P., Putzbach, K., Hentschel, P., Albert, K., and Götz, F. (2005) Structure and biosynthesis of staphyloxanthin from Staphylococcus aureus. J. Biol. Chem. 280, 32493-32498
72. Langston, K. G., Worsham, L. M., Earls, L., and Ernst-Fonberg, M. L. (2004) Activation of hemolysin toxin: relationship between two internal protein sites of acylation. Biochemistry 43, 4338-4346
73. Jiang, Y., Morgan-Kiss, R. M., Campbell, J. W., Chan, C. H., and Cronan, J. E. (2010) Expression of Vibrio harveyi acyl-ACP synthetase allows efficient entry of exogenous fatty acids into the Escherichia coli fatty acid and lipid A synthetic pathways. Biochemistry 49, 718-726
74. Beld, J., Finzel, K., and Burkart, M. D. (2014) Versatility of acyl-acyl carrier protein synthetases. Chem. Biol. 21, 1293-1299
75. Jernberg, C., Löfmark, S., Edlund, C., and Jansson, J. K. (2010) Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 156, 3216-3223
76. Croswell, A., Amir, E., Teggatz, P., Barman, M., and Salzman, N. H. (2009) Prolonged impact of antibiotics on intestinal microbial ecology and susceptibility to enteric Salmonella infection. Infect. Immun. 77, 2741-2753
77. Cho, I., Yamanishi, S., Cox, L., Methé, B. A., Zavadil, J., Li, K., Gao, Z., Mahana, D., Raju, K., Teitler, I., Li, H., Alekseyenko, A. V., and Blaser, M. J. (2012) Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 488, 621-626